|
FAM161B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.85584880796341E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.03159719550194E-11 |
| Normal-vs-Stage2 |
1.167680E-04 |
| Normal-vs-Stage3 |
1.97180050065526E-10 |
| Normal-vs-Stage4 |
4.65290028728305E-10 |
| Stage1-vs-Stage2 |
2.490400E-01 |
| Stage1-vs-Stage3 |
3.095600E-01 |
| Stage1-vs-Stage4 |
6.141800E-02 |
| Stage2-vs-Stage3 |
8.453700E-02 |
| Stage2-vs-Stage4 |
2.359900E-02 |
| Stage3-vs-Stage4 |
4.188400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.54765089632747E-13 |
| Normal-vs-AfricanAmerican |
3.216200E-03 |
| Normal-vs-Asian |
3.60080000000318E-05 |
| Caucasian-vs-AfricanAmerican |
1.313600E-01 |
| Caucasian-vs-Asian |
2.515600E-01 |
| AfricanAmerican-vs-Asian |
5.974800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.5708002393543E-10 |
| Normal-vs-Female |
2.66749955457612E-11 |
| Male-vs-Female |
3.886000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.5307002594086E-10 |
| Normal-vs-Age(41-60Yrs) |
1.24340004958867E-09 |
| Normal-vs-Age(61-80Yrs) |
1.68379998832791E-09 |
| Normal-vs-Age(81-100Yrs) |
3.986500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.358800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.511200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.259800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.912810E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.950000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.203200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.360700E-03 |
| Classical-VS-Follicular |
2.972200E-01 |
| Classical-VS-Other |
3.830600E-01 |
| Classical-VS-Normal |
1.49170000018906E-07 |
| Tall-VS-Follicular |
8.395900E-02 |
| Tall-VS-Other |
8.142600E-01 |
| Tall-VS-Normal |
5.31260035963044E-10 |
| Follicular-VS-Other |
6.499400E-01 |
| Follicular-VS-Normal |
2.94119999466602E-08 |
| Other-VS-Normal |
6.079600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.53940005187536E-09 |
| Normal-vs-N1 |
7.39710515063052E-11 |
| N0-vs-N1 |
1.260230E-02 |
|
|
